IRIS

Fagiolini, A. (2016). How can we help patients with major depressive disorder (MDD) and schizophrenia to gain the most benefit from their treatment?. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 26, 763-764 [10.1016/S0924-977X(16)31935-6].

How can we help patients with major depressive disorder (MDD) and schizophrenia to gain the most benefit from their treatment?

FAGIOLINI, ANDREA
2016-01-01
2016
Fagiolini, A. (2016). How can we help patients with major depressive disorder (MDD) and schizophrenia to gain the most benefit from their treatment?. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 26, 763-764 [10.1016/S0924-977X(16)31935-6].
1.5 Abstract in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1008300